In Vivo pan CAR therapy utilizing circular RNA for treatment of autoimmune diseases
David Soto, Isin Dalkilic-Liddle(Forma Therapeutics (United States)), Rajat S. Das(Forma Therapeutics (United States)), Matthew Theisen(Dana-Farber Cancer Institute), Juliet Crabtree(Unknown), Magnolia Chinn(Forma Therapeutics (United States)), Joe Bolen(Forma Therapeutics (United States)), Prapti Vyas, Akinola Olumide Emmanuel(University of Chicago), Muthusamy Jayaraman(Forma Therapeutics (United States)), Megan D. Hoban(Fate Therapeutics (United States)), Thomas Lee(University of Wollongong), Maja Sedic(Forma Therapeutics (United States)), Karolina Kosakowska(Forma Therapeutics (United States)), Frank Neumann(Forma Therapeutics (United States))
Cited by 4
Related Papers
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|Angewandte Chemie International Edition|2012|1.2k
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
|Molecular Therapy|2010|1.2k
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
|Nature Biotechnology|2008|1.2k